- Investing Ideas
- /
- Indian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Indian Pharmaceuticals & Biotech Solid Balance Sheet and Fundamentals
Results
16
1 new
High return on equity, past performance and sound balance sheet.
16 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
500660 | ₹2,508.80 | 24.3% | 15.7% | ₹425.0b | ₹2,617.75 | PE49.5x | E12.5% | 1.3% | ||
500488 | ₹28,944.20 | 3.9% | 0.9% | ₹615.0b | ₹29,838.57 | PE46.1x | E11.2% | 1.4% | ||
500420 | ₹3,035.75 | 0.8% | 15.6% | ₹1.0t | ₹3,639.83 | PE55.2x | E23.3% | 0.9% | ||
BLUEJET | ₹749.55 | 3.6% | 109.3% | ₹130.0b | ₹780.00 | PE55.4x | E20.2% | 0.1% | ||
AJANTPHARM | ₹2,606.50 | 1.8% | 22.6% | ₹325.5b | ₹3,029.90 | PE36.3x | E16.7% | 2.1% | ||
524742 | ₹2,030.10 | 6.0% | 35.6% | ₹154.3b | ₹2,470.00 | PE29.9x | E13.6% | 0.2% | ||
NATCOPHARM | ₹797.95 | -9.7% | -22.4% | ₹142.9b | ₹1,153.17 | PE7.7x | E-29.2% | 0.8% | ||
JAGSNPHARM | ₹219.64 | -4.4% | 78.7% | ₹14.6b | n/a | PE27.9x | n/a | 0.9% | ||
531569 | ₹272.20 | -4.1% | 54.9% | ₹3.2b | n/a | PE45.1x | n/a | n/a | ||
540737 | ₹738.80 | -4.7% | 5.7% | ₹9.5b | n/a | PE33.3x | n/a | 0% | ||
INDSWFTLAB | ₹93.58 | 1.8% | -16.6% | ₹5.5b | n/a | PE1.6x | n/a | n/a | ||
JSLL | ₹1,788.25 | -0.3% | 102.9% | ₹44.5b | n/a | PE52.8x | n/a | 0.2% | ||
544353 New | ₹91.95 | -6.6% | n/a | ₹1.8b | n/a | PE14.7x | n/a | n/a | ||
500126 | ₹5,290.50 | 1.3% | 4.1% | ₹87.8b | n/a | PE37.1x | E8.2% | 3.0% | ||
SATKARTAR | ₹173.50 | -8.7% | n/a | ₹2.7b | n/a | PE43.3x | n/a | n/a | ||
NIRMAN | ₹265.80 | -0.2% | -3.1% | ₹1.6b | n/a | PE7.4x | n/a | 0.8% |
Page 1 of 1